Defective Schwann cell lipid metabolism alters plasma membrane dynamics in Charcot-Marie-Tooth disease 1A-Reference-Cited by-同舟云学术

Defective Schwann cell lipid metabolism alters plasma membrane dynamics in Charcot-Marie-Tooth disease 1A

Published:2023-04-02 Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

Prior Robert^ORCID,Silva Alessio^ORCID,Vangansewinkel Tim^ORCID,Idkowiak Jakub^ORCID,Tharkeshwar Arun Kumar^ORCID,Hellings Tom P.^ORCID,Michailidou Iliana^ORCID,Vreijling Jeroen^ORCID,Loos Maarten^ORCID,Koopmans Bastijn^ORCID,Vlek Nina,Straat Nina,Agaser Cedrick,Kuipers Tom^ORCID,Michiels Christine,Rossaert Elisabeth^ORCID,Verschoren Stijn^ORCID,Vermeire Wendy,de Laat Vincent^ORCID,Dehairs Jonas^ORCID,Eggermont Kristel^ORCID,van den Biggelaar Diede,Bademosi Adekunle T.^ORCID,Meunier Frederic A.^ORCID,vandeVen Martin,Van Damme Philip^ORCID,Mei Hailiang,Swinnen Johannes V.^ORCID,Lambrichts Ivo^ORCID,Baas Frank^ORCID,Fluiter Kees^ORCID,Wolfs Esther^ORCID,Den Bosch Ludo Van^ORCID

Abstract

AbstractDuplication ofPMP22causes Charcot-Marie-Tooth disease type 1A (CMT1A) and is known to disrupt the lipid metabolism in myelinating Schwann cells by unknown mechanisms. By using two CMT1A mouse models overexpressing humanPMP22, we discovered thatPMP22dose-dependently downregulates genes that are involved in lipid and cholesterol metabolism. Lipidomic analysis on CMT1A mouse sciatic nerves confirmed lipid metabolic abnormalities primarily associated with cholesterol and sphingolipids. We observed similar lipidomic profiles and downregulation of genes associated with lipid metabolism in human CMT1A patient induced pluripotent stem cell-derived Schwann cell precursors (iPSC-SCPs). We confirmed these findings by demonstrating altered lipid raft dynamics and plasma membrane fluidity in CMT1A iPSC-SCPs. Additionally, we identified impaired cholesterol incorporation in the plasma membrane due to altered lipid storage homeostasis in CMT1A iPSC-SCPs, which could be modulated by changing the lipid composition of the cell culture medium. These findings suggest that PMP22 plays a role in regulating the lipid composition of the plasma membrane and lipid storage homeostasis. Targeting lipid metabolism may hold promise as a potential treatment for CMT1A patients.Graphical abstractHighlights

PMP22copy number causes a dose-dependent suppression of cholesterol and lipid biosynthesis in peripheral nerves of CMT1A mice

Lipid composition is altered in the sciatic nerves of CMT1A mice and in the membranes of patient derived iPSC-SCPs, with a significant reduction in sphingolipids

CMT1A iPSC-SCPs show decreased plasma membrane lipids required for regulating lipid raft dynamics, membrane fluidity, and membrane order

Lipid storage misregulation is key in the pathogenesis of CMT1A

Publisher

Cold Spring Harbor Laboratory

Reference102 articles.

1. Developmental abnormalities in the nerves of peripheral myelin protein 22-deficient mice

2. Spectral imaging toolbox: segmentation, hyperstack reconstruction, and batch processing of spectral images for the determination of cell and model membrane lipid order

3. In vivo single-molecule imaging of syntaxin1A reveals polyphosphoinositide- and activity-dependent trapping in presynaptic nanoclusters

4. HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease

5. Molecular organization of axo-glial junctions